Indication
Vascular Type
2 clinical trials
2 products
3 drugs
Clinical trial
Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Placebo Controlled, Multicenter Trial.Status: Completed, Estimated PCD: 2020-02-19
Product
IrbesartanDrug
VarlilumabClinical trial
Efficacy and Safety of Tocilizumab and Tofacitinib in the Treatment of Patients With Vascular Behçet's SyndromeStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Product
tocilizumabDrug
tofacitinibDrug
cyclophosphamide